GnRH agonists also sensitized and re-sensitized docetaxel-resistant PCa cells to docetaxel, but failed to do so if TP53 was absent, indicating that a functional p53 protein was necessary in combination treatment of GnRH agonists and docetaxel re-challenge [41]. Here, TP53 is linked to posterior cortical atrophy.